Jane A. Estell
Impact in
- Pathology and Forensic Medicine top 0.5%
- Lymphoma Diagnosis and Treatment
- Hematology top 5%
- Multiple Myeloma Research and Treatments
- Platelet Disorders and Treatments
Papers in
- Hematology 13
- Multiple Myeloma Research and Treatments 10
- Platelet Disorders and Treatments 2
- Hematopoietic Stem Cell Transplantation 1
-
- Lymphoma Diagnosis and Treatment 10
- Co-authors
- María‐Victoria Mateos (2 shared papers)Ajay K. Nooka (2 shared papers)Chang‐Ki Min (2 shared papers)Paolo Corradini (2 shared papers)Eva Medvedova (2 shared papers)Wolney Góis Barreto (2 shared papers)Himal Amin (2 shared papers)Xiang Qin (2 shared papers)
- Journals
- Blood (7 papers)Journal of Clinical Oncology (2 papers)British Journal of Haematology (2 papers)Haematologica (2 papers)The Lancet (1 paper)
- Partner nations
- AustraliaUnited StatesFrance
In The Last Decade
Jane A. Estell
23 papers receiving 1.8k citations
Jane A. Estell's Hit Papers
Peers
Comparison fields: 5 of 36
- Pathology and Forensic Medicine 1.2k
- Hematology 267
- Genetics 45
- Oncology 43
- Radiology, Nuclear Medicine and Imaging 37
Countries citing papers authored by Jane A. Estell
This map shows the geographic impact of Jane A. Estell's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jane A. Estell with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jane A. Estell more than expected).
Fields of papers citing papers by Jane A. Estell
This network shows the impact of papers produced by Jane A. Estell. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jane A. Estell. The network helps show where Jane A. Estell may publish in the future.
Co-authors
The 25 scholars most cited alongside Jane A. Estell, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 25 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Rituximab maintenance for 2 years in patients with high tumour burden follicular lymphoma responding to rituximab plus chemotherapy (PRIMA): a phase 3, randomised controlled trial Hit paper breakdown → | 2010 | 844 |
| 2 | 2019 | 221 | |
| 3 | 2018 | 170 | |
| 4 | 2011 | 159 | |
| 5 | 2019 | 125 | |
| 6 | 2020 | 69 | |
| 7 | 2013 | 67 | |
| 8 | Long term follow-up of the PRIMA study : half of patients receiving rituximab maintenance remain progression free at 10 years | 2017 | 38 |
| 9 | 2007 | 31 | |
| 10 | 2016 | 31 | |
| 11 | 2023 | 17 | |
| 12 | 2010 | 8 | |
| 13 | 2016 | 6 | |
| 14 | 2016 | 6 | |
| 15 | Rituximab maintenance for 2-years significantly improves the outcome of patients with untreated high tumor burden follicular lymphoma after response to immunochemotherapy: results of the PRIMA study | 2010 | 5 |
| 16 | 2008 | 3 | |
| 17 | 2010 | 3 | |
| 18 | 2021 | 2 | |
| 19 | 2008 | 1 | |
| 20 | 2014 | 1 |
About Jane A. Estell
Jane A. Estell is a scholar working on Hematology, Pathology and Forensic Medicine, Oncology, Nuclear Energy and Engineering and Waste Management and Disposal, having authored 25 papers that have together received 1.8k indexed citations. Recurring topics across this work include Lymphoma Diagnosis and Treatment (10 papers), Multiple Myeloma Research and Treatments (10 papers), Platelet Disorders and Treatments (2 papers), Hematopoietic Stem Cell Transplantation (1 paper) and Polyomavirus and related diseases (1 paper). The work is most often cited by research in Pathology and Forensic Medicine (1.2k citations), Hematology (267 citations), Genetics (45 citations), Oncology (43 citations) and Radiology, Nuclear Medicine and Imaging (37 citations). Jane A. Estell has collaborated with scholars based in Australia, United States and France. Frequent co-authors include María‐Victoria Mateos, Ajay K. Nooka, Chang‐Ki Min, Paolo Corradini, Eva Medvedova, Wolney Góis Barreto, Himal Amin, Xiang Qin, Jordan Mark Schecter and Andrew G Spencer. Their work appears in journals such as Blood, Journal of Clinical Oncology, British Journal of Haematology, Haematologica and The Lancet.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.